Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
ABOUT THIS PAGE
18
PharmaCompass offers a list of Revumenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Revumenib manufacturer or Revumenib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Revumenib manufacturer or Revumenib supplier.
PharmaCompass also assists you with knowing the Revumenib API Price utilized in the formulation of products. Revumenib API Price is not always fixed or binding as the Revumenib Price is obtained through a variety of data sources. The Revumenib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A SNDX-5613 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SNDX-5613, including repackagers and relabelers. The FDA regulates SNDX-5613 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SNDX-5613 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A SNDX-5613 supplier is an individual or a company that provides SNDX-5613 active pharmaceutical ingredient (API) or SNDX-5613 finished formulations upon request. The SNDX-5613 suppliers may include SNDX-5613 API manufacturers, exporters, distributors and traders.
click here to find a list of SNDX-5613 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing SNDX-5613 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for SNDX-5613 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture SNDX-5613 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain SNDX-5613 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a SNDX-5613 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of SNDX-5613 suppliers with NDC on PharmaCompass.
SNDX-5613 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SNDX-5613 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SNDX-5613 GMP manufacturer or SNDX-5613 GMP API supplier for your needs.
A SNDX-5613 CoA (Certificate of Analysis) is a formal document that attests to SNDX-5613's compliance with SNDX-5613 specifications and serves as a tool for batch-level quality control.
SNDX-5613 CoA mostly includes findings from lab analyses of a specific batch. For each SNDX-5613 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SNDX-5613 may be tested according to a variety of international standards, such as European Pharmacopoeia (SNDX-5613 EP), SNDX-5613 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SNDX-5613 USP).
